Retraction: Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer.
出版信息
Cancer Res. 2018 Jun 15;78(12):3397. doi: 10.1158/0008-5472.CAN-18-1182.
Abstract
摘要
相似文献
1
Retraction: Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer.
Cancer Res. 2018 Jun 15;78(12):3397. doi: 10.1158/0008-5472.CAN-18-1182.
2
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
Cancer Res. 2007 Feb 1;67(3):930-9. doi: 10.1158/0008-5472.CAN-06-2892.
3
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer.
J Urol. 2009 Mar;181(3):1393-400. doi: 10.1016/j.juro.2008.10.147. Epub 2009 Jan 20.
4
Retraction: Small Interfering RNA-Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis.
Cancer Res. 2018 Jun 15;78(12):3398. doi: 10.1158/0008-5472.CAN-18-1183.
5
Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Cell Physiol Biochem. 2017;41(4):1313-1324. doi: 10.1159/000464434. Epub 2017 Mar 8.
6
Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
Cancer. 1996 Mar 15;77(6):1079-88. doi: 10.1002/(sici)1097-0142(19960315)77:6<1079::aid-cncr12>3.0.co;2-z.
7
8
Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Prostate. 1996 Apr;28(4):239-50. doi: 10.1002/(SICI)1097-0045(199604)28:4<239::AID-PROS5>3.0.CO;2-8.
9
Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs.
Am J Vet Res. 2006 Sep;67(9):1628-34. doi: 10.2460/ajvr.67.9.1628.
10
The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer.
J Urol. 1994 Jan;151(1):16-9; discussion 19-20. doi: 10.1016/s0022-5347(17)34861-9.
本文引用的文献
1
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
Cancer Res. 2007 Feb 1;67(3):930-9. doi: 10.1158/0008-5472.CAN-06-2892.
Zotero 插件